scholarly journals 1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G2/M phase

2017 ◽  
Vol 38 (4) ◽  
pp. 561-570 ◽  
Author(s):  
Chun Peng ◽  
Xin-ming Qi ◽  
Ling-ling Miao ◽  
Jin Ren

2020 ◽  
Vol 52 (2) ◽  
pp. 168-179 ◽  
Author(s):  
Huilin Gong ◽  
Shan Gao ◽  
Chenghuan Yu ◽  
Meihe Li ◽  
Ping Liu ◽  
...  

Abstract Y-box binding protein 1 (YB-1) is manifested as its involvement in cell proliferation and differentiation and malignant cell transformation. Overexpression of YB-1 is associated with glioma progression and patient survival. The aim of this study is to investigate the influence of YB-1 knockdown on glioma cell progression and reveal the mechanisms of YB-1 knockdown on glioma cell growth, migration, and apoptosis. It was found that the knockdown of YB-1 decreased the mRNA and protein levels of YB-1 in U251 glioma cells. The knockdown of YB-1 significantly inhibited cell proliferation, colony formation, and migration in vitro and tumor growth in vivo. Proteome and phosphoproteome data revealed that YB-1 is involved in glioma progression through regulating the expression and phosphorylation of major proteins involved in cell cycle, adhesion, and apoptosis. The main regulated proteins included CCNB1, CCNDBP1, CDK2, CDK3, ADGRG1, CDH-2, MMP14, AIFM1, HO-1, and BAX. Furthermore, it was also found that YB-1 knockdown is associated with the hypo-phosphorylation of ErbB, mTOR, HIF-1, cGMP-PKG, and insulin signaling pathways, and proteoglycans in cancer. Our findings indicated that YB-1 plays a key role in glioma progression in multiple ways, including regulating the expression and phosphorylation of major proteins associated with cell cycle, adhesion, and apoptosis.



2007 ◽  
Vol 13 (8) ◽  
pp. 2441-2448 ◽  
Author(s):  
David L. Gillespie ◽  
Kum Whang ◽  
Brian T. Ragel ◽  
Jeannette R. Flynn ◽  
David A. Kelly ◽  
...  


2008 ◽  
Vol 327 (1) ◽  
pp. 10-19 ◽  
Author(s):  
Austin M. Guo ◽  
Ju Sheng ◽  
Gloria M. Scicli ◽  
Ali S. Arbab ◽  
Norman L. Lehman ◽  
...  


2010 ◽  
Vol 21 (3) ◽  
pp. 303-314 ◽  
Author(s):  
Yu Ren ◽  
Chun-Sheng Kang ◽  
Xu-Bo Yuan ◽  
Xuan Zhou ◽  
Peng Xu ◽  
...  


2010 ◽  
Vol 13 (2) ◽  
pp. 155-164 ◽  
Author(s):  
G. Eisele ◽  
P. Roth ◽  
K. Hasenbach ◽  
S. Aulwurm ◽  
F. Wolpert ◽  
...  




2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Wangsheng Chen ◽  
Lan Hong ◽  
Changlong Hou ◽  
Yibin Wang ◽  
Fei Wang ◽  
...  

Abstract Background MicroRNAs (miRNAs) are important regulators for cancer cell proliferation. miR-585 has been shown to inhibit the proliferation of several types of cancer, however, little is known about its role in human glioma cells. Methods miR-585 levels in human glioma clinical samples and cell lines were examined by quantitative real-time PCR (qRT-PCR) analysis. Cell proliferation was measured by Cell Counting Kit-8 (CCK-8) and EdU incorporation assays in vitro. For in vivo investigations, U251 cells were intracranially inoculated in BALB/c nude mice and xenografted tumors were visualized by magnetic resonance imaging (MRI). Results miR-585 expression is downregulated in human glioma tissues and cell lines compared with non-cancerous counterparts. Additionally, miR-585 overexpression inhibits and its knockdown promotes human glioma cell proliferation in vitro. Moreover, miR-585 overexpression also inhibits the growth of glioma xenografts in vivo, suggesting that miR-585 may act as a tumor suppressor to inhibit the proliferation of human glioma. Furthermore, miR-585 directly targets and decreases the expression of oncoprotein murine double minute 2 (MDM2). More importantly, the restoration of MDM2 via enforced overexpression markedly rescues miR-585 inhibitory effect on human glioma cell proliferation, thus demonstrating that targeting MDM2 is a critical mechanism by which miR-585 inhibits human glioma cell proliferation. Conclusions Our study unveils the anti-proliferative role of miR-585 in human glioma cells, and also implicates its potential application in clinical therapy.



2015 ◽  
Vol 36 (4) ◽  
pp. 1012-1018 ◽  
Author(s):  
BING ZHAO ◽  
GANG ZONG ◽  
YONGSHENG XIE ◽  
JIA LI ◽  
HONGLIANG WANG ◽  
...  


1983 ◽  
Vol 48 (6) ◽  
pp. 819-825 ◽  
Author(s):  
N J Bradley ◽  
J L Darling ◽  
N Oktar ◽  
H J Bloom ◽  
D G Thomas ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document